Literature DB >> 11905805

How melanoma cells evade trail-induced apoptosis.

P Hersey1, X D Zhang.   

Abstract

At the doses used clinically, chemotherapy is believed to kill melanoma by a final common 'mitochondrial' pathway that leads to apoptosis. Similarly, several natural defence mechanisms kill melanoma by the same pathways. A corollary to the latter is that survival of melanoma in the host is due to the development of anti-apoptotic mechanisms in melanoma cells. What are these mechanisms? And how might we bypass them to improve the treatment of melanoma?

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11905805     DOI: 10.1038/35101078

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  49 in total

1.  Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  Alexander Kotelkin; Elena A Prikhod'ko; Jeffrey I Cohen; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 2.  Current position of TNF-α in melanomagenesis.

Authors:  Iuliana Nenu; Diana Tudor; Adriana Gabriela Filip; Ioana Baldea
Journal:  Tumour Biol       Date:  2015-08-18

3.  Constitutional promoter methylation and risk of familial melanoma.

Authors:  Paula L Hyland; Laura S Burke; Ruth M Pfeiffer; Melissa Rotunno; David Sun; Prasad Patil; Xiaolin Wu; Margaret A Tucker; Alisa M Goldstein; Xiaohong Rose Yang
Journal:  Epigenetics       Date:  2014-02-13       Impact factor: 4.528

4.  Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells.

Authors:  Hyeon-Ok Jin; Yun-Han Lee; Jin-Ah Park; Ha-Na Lee; Jin-Hee Kim; Ji-Young Kim; BoRa Kim; Sung-Eun Hong; Hyun-Ah Kim; Eun-Kyu Kim; Woo Chul Noh; Jong-Il Kim; Yoon Hwan Chang; Seok-Il Hong; Young-Jun Hong; In-Chul Park; Jin Kyung Lee
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-15       Impact factor: 4.553

5.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

6.  Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Exp Cell Res       Date:  2006-09-28       Impact factor: 3.905

7.  Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival.

Authors:  Geoffrey E Johnson; Vladimir N Ivanov; Tom K Hei
Journal:  Apoptosis       Date:  2008-06       Impact factor: 4.677

Review 8.  The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma.

Authors:  Antonio Romo de Vivar Chavez; Michael E de Vera; Xiaoyan Liang; Michael T Lotze
Journal:  Med Oncol       Date:  2009-01-16       Impact factor: 3.064

Review 9.  Chemoprevention of melanoma.

Authors:  Marie-France Demierre; Glenn Merlino
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

10.  2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2.

Authors:  Hao Liu; Chen Chen Jiang; Christopher J Lavis; Amanda Croft; Li Dong; Hsin-Yi Tseng; Fan Yang; Kwang Hong Tay; Peter Hersey; Xu Dong Zhang
Journal:  Mol Cancer       Date:  2009-12-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.